FindTrial
Sign In

A clinical trial to study the effects of intralesional tranexamic acid versus flucinolone based triple combination in melasma

INTRALESIONAL TRANEXAMIC ACID VERSUS FLUCINOLONE BASED TRIPLE COMBINATION IN MELASMA-A COMPARATIVE TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/12/016678
Enrollment
94
Registered
2018-12-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

Intervention1: tranexamic acid injections: intralesional tranexamic acid injections Control Intervention1: flucinolone based triple combination-TRILUMA cream: flucinolone acetonide 0.01%,tretinoin 0.0

Sponsors

SRM MEDICAL COLLEGE HOSPITAL
Lead Sponsor
SRM MEDICAL COLLEGE HOSPITAL
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: patients willing to undergo treatment and come for followup are included in the study

Exclusion criteria

Exclusion criteria: patients not willing for followup;having unrealistic expectations from the treatment;on other melasma therapies within last 6 months;who refuse to allow photographs

Design outcomes

Primary

MeasureTime frame
MASI SCORE colour photographsTimepoint: baseline,4 weeks and 8weeks—

Secondary

MeasureTime frame
followup for further improvemnt or relapseTimepoint: followed up for 3 months—

Countries

India

Contacts

Public ContactDrmurali narasimhan

SRM MEDICAL COLLEGE

leecutis@gmail.com9840168711

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026